
Stemnode Pharmaceuticals Private Limited
About Stemnode Pharmaceuticals Private Limited
Data last updated:
Stemnode Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diversified business activities segment of the business services sector. It was incorporated on 07 September 2016.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC305574.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Subhash Chandra Kesarwani and Sajjad Hassan.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at H.No 7 G/ Floor R/Poration Vijay Market Vill Madan Pur Khadar Sarita Vihar Opp D, Eep Dairy, New Delhi, Delhi, India – 110076.
As per the financials filed for FY 2018, the company reported a revenue of ₹26,817. For the same year it recorded a net loss of ₹1.78 Lakh and EBITDA of -₹1.7 Lakh.
Company details
Contact details
Stemnode Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressH.No 7 G/ Floor R/Poration Vijay Market Vill Madan Pur Khadar Sarita Vihar Opp D, Eep Dairy, New Delhi, Delhi, India – 110076
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stemnode Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stemnode Pharmaceuticals Private Limited, buy the company report.
Financials of Stemnode Pharmaceuticals Private Limited
FY 2018 filings availableStemnode Pharmaceuticals Private Limited reported revenue of ₹26,817 for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.7 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.78 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Stemnode Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stemnode Pharmaceuticals Private Limited
Stemnode Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sajjad Hassan | Additional Director | 30 Dec 2017 | 8 Years 10 Months | As last reported |
| Subhash Chandra Kesarwani | Director | 07 Sep 2016 | 10 Years 1 Months | As last reported |
Peer comparison
Stemnode Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medcloud Pharmaceuticals Private Limited | ₹27,286 (FY 2025) | -87.0% | New Delhi, Delhi, India | |||
| Stemnode Pharmaceuticals Private Limitedthis company | ₹26,817 (FY 2018) | -₹1.78 Lakh | New Delhi, Delhi, India | |||
| Viv Pharmaceuticals Private Limited | ₹26,600 (FY 2024) | -89.0% | Lucknow, Uttar Pradesh, India | |||
| Prelude Pharmaceuticals Private Limited | ₹26,220 (FY 2024) | -11.0% | Allahabad, Uttar Pradesh, India | |||
| Fitbeing Pharmaceuticals Private Limited | ₹25,966 (FY 2023) | Etawah, Uttar Pradesh, India |
To see the full peer comparison of Stemnode Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Stemnode Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stemnode Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Stemnode Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Stemnode Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Manak Chand Verma ceased to be Director on 30 Dec 2017.
Frequently asked questions
Stemnode Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Stemnode Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in miscellaneous business activities, within the business services industry. It was incorporated on 07 September 2016 and is registered under CIN U74999DL2016PTC305574. The company has been struck off by the Registrar of Companies and is no longer operational.
Stemnode Pharmaceuticals had 2 directors:
- Sajjad Hassan - Additional Director
- Subhash Chandra Kesarwani - Director
The CIN (Corporate Identification Number) of Stemnode Pharmaceuticals is U74999DL2016PTC305574. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Stemnode Pharmaceuticals is at H.No 7 G Floor RPoration Vijay Market Vill Madan Pur Khadar Sarita Vihar Opp D, Eep Dairy, New Delhi, Delhi, India – 110076.
Stemnode Pharmaceuticals was incorporated on 07 September 2016. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Stemnode Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2017 are in the company report.
Stemnode Pharmaceuticals operated in the business services industry, in the miscellaneous business activities segment. It worked in this industry before it was struck off.
The peers of Stemnode Pharmaceuticals by revenue are Medcloud Pharmaceuticals Private Limited, Viv Pharmaceuticals Private Limited, Prelude Pharmaceuticals Private Limited, Fitbeing Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manak Chand Verma ceased to be Director on 30 Dec 2017. Sajjad Hassan was appointed as Additional Director on 30 Dec 2017. Subhash Chandra Kesarwani was appointed as Director on 07 Sep 2016.
The compliance status of Stemnode Pharmaceuticals is active non-compliant as of 19 July 2026.

